Bifunctional antibodies and their potential clinical applications
International Journal of Clinical & Laboratory Research · 1992
DOI: 10.1007/bf02591389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Clinical & Laboratory Research, 1992. Verfasst von O Nolan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Applied Biochemistry Group, School of Biological Sciences, Dublin City University, Glasnevin, Ireland. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Bifunctional antibodies are monovalent, bispecific, antibody-derived molecules. They have been produced by both chemical and biological means. They are thought to have several advantages over monoclonal antibodies in both immunotherapy and immunodiagnosis. Bifunctional antibodies have been shown to be efficient in the targeting of drugs, toxins, radiolabelled haptens and effector cells on to diseased tissues, primarily cancer cells. In addition, bifunctional antibodies have been used to develop novel immunoassays. The full potential of bifunctional antibodies has yet to be realised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Applied Biochemistry Group, School of Biological Sciences, Dublin City University, Glasnevin, Ireland.
Zitieren
APA
Nolan, O., & O'Kennedy, R. (1992). Bifunctional antibodies and their potential clinical applications. International Journal of Clinical & Laboratory Research. https://doi.org/10.1007/bf02591389
Vancouver
Nolan O, O'Kennedy R. Bifunctional antibodies and their potential clinical applications. International Journal of Clinical & Laboratory Research. 1992. doi:10.1007/bf02591389
BibTeX
@article{Nolan1992,
author = {Nolan, O and O'Kennedy, R},
title = {Bifunctional antibodies and their potential clinical applications},
journal = {International Journal of Clinical & Laboratory Research},
year = {1992},
doi = {10.1007/bf02591389}
}
EUVIMED